Stefan Loren

Stefan D.
Loren is the founder of Loren Capital Strategy LLC, founded in 2014.
Current jobs include Managing Director at Oppenheimer & Co., Inc. since 2017, Independent Director at Cellectar Biosciences, Inc. since 2015, and Advisory Board member at Prevail Partners LLC.
Former jobs include Managing Director-Healthcare Group at Legg Mason, Inc. from 1997 to 2005, Board Director at GenVec, Inc. from 2013 to 2017, Director at Orchid Cellmark, Inc., Director at PolyMedix, Inc. from 2008 to 2011, Managing Director at Legg Mason Wood Walker, Inc. in 2005, Alumni Board Director at the University of California San Diego from 2010 to 2015, Lead Independent Director at Adhera Therapeutics, Inc. from 2012 to 2017, Managing Director at Westwicke Partners LLC from 2008 to 2014, Research Chemist-Advanced Technologies Division at Abbott Laboratories, Board Member at Orchid Cellmark, Inc. from 2010 to 2011, Analyst at Perceptive Advisors LLC from 2007 to 2008, Board member at Adhera Therapeutics, Inc., Advisor at Numoda Capital Innovations LLC, and Portfolio Manager at MTB Investment Advisors, Inc. Education includes a doctorate from the University of California, Berkeley, conferred in 1992, and an undergraduate degree from the University of California San Diego, conferred in 1987.